Back
Atea Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
AVIR
Atea Pharmaceuticals
Last Price:
$3.53
Seasonality Move:
-28.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and AVIR is experiencing slight buying pressure.
Atea Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.48 | Buy |
| 20-day SMA: | 3.56 | Sell |
| 50-day SMA: | 3.49 | Buy |
| 200-day SMA: | 3.19 | Buy |
| 8-day EMA: | 3.5 | Sell |
| 20-day EMA: | 3.53 | Sell |
| 50-day EMA: | 3.45 | Buy |
| 200-day EMA: | 3.3 | Buy |
Atea Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | 175359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.42 - 3.7) | Sell |
| Bollinger Bands (100): | (2.84 - 3.54) | Buy |
Atea Pharmaceuticals Technical Analysis
| Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atea Pharmaceuticals Stock
Is Atea Pharmaceuticals Stock a Buy?
-
Atea Pharmaceuticals share price is 3.50 while AVIR 8-day simple moving average is 3.48, which is a Buy signal.
-
The stock price of AVIR is 3.50 while Atea Pharmaceuticals 20-day SMA is 3.56, which makes it a Sell.
-
Atea Pharmaceuticals 50-day simple moving average is 3.49 while AVIR share price is 3.50, making it a Buy technically.
-
AVIR stock price is 3.50 and Atea Pharmaceuticals 200-day simple moving average is 3.19, creating a Buy signal.
AVIR Technical Analysis vs Fundamental Analysis
Sell
39
Atea Pharmaceuticals (AVIR)
is a Sell
Is Atea Pharmaceuticals a Buy or a Sell?
-
Atea Pharmaceuticals stock is rated a SellThe current Atea Pharmaceuticals [AVIR] share price is $3.50. The Score for AVIR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Atea Pharmaceuticals Stock Info
Market Cap:
277.8M
Price in USD:
3.50
Share Volume:
398.5K
Atea Pharmaceuticals 52-Week Range
52-Week High:
4.15
52-Week Low:
2.46
Sell
39
Atea Pharmaceuticals (AVIR)
is a Sell
Atea Pharmaceuticals Share Price Forecast
-
What is the Atea Pharmaceuticals stock price today?The Atea Pharmaceuticals stock price is 3.50 USD today.
-
Will AVIR stock go up or go down?Atea Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Atea Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atea Pharmaceuticals is overvalued.
Is Atea Pharmaceuticals Stock a Buy?
-
Atea Pharmaceuticals share price is 3.50 while AVIR 8-day exponential moving average is 3.50, which is a Sell signal.
-
The stock price of AVIR is 3.50 while Atea Pharmaceuticals 20-day EMA is 3.53, which makes it a Sell.
-
Atea Pharmaceuticals 50-day exponential moving average is 3.45 while AVIR share price is 3.50, making it a Buy technically.
-
AVIR stock price is 3.50 and Atea Pharmaceuticals 200-day simple moving average is 3.30, creating a Buy signal.
Fundamental Analysis of Atea Pharmaceuticals
Is Atea Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.17 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Atea Pharmaceuticals
Should I short Atea Pharmaceuticals stock?
-
AVIR Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Atea Pharmaceuticals is a Sell
-
Atea Pharmaceuticals Relative Strength Index (RSI) is 48.71, which suggest Atea Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Atea Pharmaceuticals is (3.42 - 3.7), which suggest Atea Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Atea Pharmaceuticals is (2.84 - 3.54), which suggest Atea Pharmaceuticals is a Buy
* Atea Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.